nifedipine has been researched along with cilazapril, anhydrous in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (81.82) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Derman, WE; Noakes, TD; Sims, R | 1 |
| Abaterusso, C; Brocco, E; Carraro, A; Cipollina, MR; Fioretto, P; Frigato, F; Muollo, B; Riva, F; Trevisan, M; Velussi, M | 1 |
| Bulpitt, CJ; Chase, DM; Collins, WC; Fletcher, AE; Furberg, CD; Goggin, TK; Hewett, AJ; Neiss, AM | 1 |
| Fukuda, T; Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Yagi, K; Yukimura, T | 1 |
| Athanázio-Heliodoro, RC; Franco, RJ; Marcondes, M; Martin, LC; Mion Júnior, D; Pascoal, IJ; Sampaio, M; Tinucci, T; Velasco-Cornejo, IF | 1 |
| Chou, TC; Ding, YA; Law, HW | 1 |
| Goggin, T; Pickering, A; Powell, J; Wyke, M | 1 |
| Li, JS; Schiffrin, EL; Sventek, P | 1 |
| Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Yukimura, T | 1 |
| Agabiti-Rosei, E; Rizzoni, D | 1 |
5 trial(s) available for nifedipine and cilazapril, anhydrous
| Article | Year |
|---|---|
The effects of antihypertensive medications on the physiological response to maximal exercise testing.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Cilazapril; Double-Blind Method; Exercise Test; Heart Rate; Humans; Lactates; Male; Nifedipine; Physical Exertion; Pyridazines; Respiration | 1992 |
Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Cilazapril; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Patient Dropouts; Pyridazines; Quality of Life | 1992 |
[Comparative and double-blind study of the efficacy and safety of cilazapril compared to nifedipine retard in the treatment of mild and moderate arterial hypertension].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Time Factors; Treatment Outcome | 1994 |
Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients.
Topics: Blood Platelets; Blood Pressure; Cilazapril; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Rheology; Time Factors | 1994 |
The effects of anti-hypertensive medication on learning and memory.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Blood Pressure; Cilazapril; Double-Blind Method; Female; Humans; Learning; Male; Memory; Middle Aged; Nifedipine; Sensitivity and Specificity | 1993 |
6 other study(ies) available for nifedipine and cilazapril, anhydrous
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Calcium Channel Blockers; Cilazapril; Diabetes Mellitus, Type 1; Female; Humans; Hypertension; Male; Nifedipine; Sodium Chloride; Verapamil | 1992 |
Transforming growth factor-beta 1 expression and phenotypic modulation in the kidney of hypertensive rats.
Topics: Actins; Animals; Blotting, Northern; Cell Division; Cilazapril; Gene Expression; Genetic Markers; Hypertension; Immunohistochemistry; Kidney; Kidney Glomerulus; Male; Nephrosclerosis; Nifedipine; Phenotype; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Staining and Labeling; Transforming Growth Factor beta; Vimentin | 1995 |
Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Body Weight; Calcium Channel Blockers; Cardiomegaly; Cilazapril; Desoxycorticosterone; Endothelin-1; Hypertension; NG-Nitroarginine Methyl Ester; Nifedipine; Organ Size; Rats; Rats, Sprague-Dawley; Renin | 1996 |
Suppression of vascular transforming growth factor-beta1 and extracellular matrix gene expressions by cilazapril and nifedipine in hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Vessels; Blotting, Northern; Calcium Channel Blockers; Cerebrovascular Disorders; Cilazapril; Extracellular Matrix; Gene Expression; Male; Nifedipine; Rats; Rats, Inbred SHR; RNA, Messenger; Transforming Growth Factor beta | 1995 |
Endothelial factors and microvascular hypertensive disease.
Topics: Acetylcholine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cilazapril; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hypertension; Lisinopril; Losartan; Nifedipine; Nitric Oxide; Rats; Rats, Inbred SHR; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2001 |